C3ORF21 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.250600E-01
Normal-vs-Stage2
8.297800E-01
Normal-vs-Stage3
7.959200E-01
Normal-vs-Stage4
3.412200E-01
Stage1-vs-Stage2
2.170600E-01
Stage1-vs-Stage3
4.988200E-01
Stage1-vs-Stage4
4.537500E-02
Stage2-vs-Stage3
7.287200E-01
Stage2-vs-Stage4
1.760620E-01
Stage3-vs-Stage4
6.382200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.749200E-01
Normal-vs-AfricanAmerican
8.884000E-01
Normal-vs-Asian
8.910400E-01
Caucasian-vs-AfricanAmerican
9.683800E-01
Caucasian-vs-Asian
5.653000E-01
AfricanAmerican-vs-Asian
7.238000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.467800E-01
Normal-vs-Female
7.282400E-01
Male-vs-Female
3.562000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.628200E-01
Normal-vs-Age(41-60Yrs)
4.926800E-01
Normal-vs-Age(61-80Yrs)
9.999400E-01
Normal-vs-Age(81-100Yrs)
7.609800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.091900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.374400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.558400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.075600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.318400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.032600E-01
Normal-vs-Daily Drinker
6.208200E-01
Normal-vs-Weekly Drinker
5.464400E-01
Normal-vs-Occasional Drinker
6.607800E-01
Normal-vs-Social Drinker
7.727200E-01
Non Drinker-vs-Daily Drinker
9.320600E-01
Non Drinker-vs-Weekly Drinker
2.864000E-02
Non Drinker-vs-Occasional Drinker
8.326100E-02
Non Drinker-vs-Social Drinker
1.219150E-01
Daily Drinker-vs-Weekly Drinker
4.268300E-02
Daily Drinker-vs-Occasional Drinker
9.905700E-02
Daily Drinker-vs-Social Drinker
1.540200E-01
Weekly Drinker-vs-Occasional Drinker
8.604400E-01
Weekly Drinker-vs-Social Drinker
5.240600E-01
Occasional Drinker-vs-Social Drinker
6.726800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.385000E-01
Normal-vs-Grade 2
6.911600E-01
Normal-vs-Grade 3
3.601400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.034900E-04
Grade 1-vs-Grade 3
3.615800E-03
Grade 1-vs-Grade 4
9.385000E-01
Grade 2-vs-Grade 3
8.980600E-01
Grade 2-vs-Grade 4
6.911600E-01
Grade 3-vs-Grade 4
3.601400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.728800E-01
Normal-vs-NonDiabetic
8.325400E-01
Diabetic-vs-NonDiabetic
2.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.321200E-01
Normal-vs-NoPancreatitis
8.987000E-01
Pancreatitis-vs-NoPancreatitis
6.119800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.284000E-01
Normal-vs-N1
7.758400E-01
N0-vs-N1
5.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.738400E-01
Normal-vs-TP53-NonMutant
8.577000E-01
TP53-Mutant-vs-TP53-NonMutant
1.918730E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
